deeptech Value proposition
Science-driven efficacy
Founded in 2010, Biomeostasis is a leading Preclinical CRO that offers in vivo research services in the fields of Metabolic, GastroIntestinal & Age-related Diseases.
For over 11 years, we have been assessing the Efficacy & Mechanisms of action of Health Products that address conditions such as Obesity, Binge-eating, Sarcopenia, Anorexia, Cachexia, Diabetes, NAFLD/NASH, Food Allergy, Constipation, IBD...
Complementary to our in vivo pharmacology services, we offer Histology and Omics enabling deciphering the efficacy and MoA of Health Products in the metabolic, GI and Ageing spaces.
Localisation : Marseille - France
preclinical, obesity, diabetes, gastrointestinal disorders, tailor-made rodent models, NAFLD, NASH, in vivo pharmacology, cachexia, muscle wasting, histology, metabolic phenotyping, IBD, and Ulcerative colitisOriginal language
Science-driven efficacy
Founded in 2010, Biomeostasis is a leading Preclinical CRO that offers in vivo research services in the fields of Metabolic, GastroIntestinal & Age-related Diseases.
For over 11 years, we have been assessing the Efficacy & Mechanisms of action of Health Products that address conditions such as Obesity, Binge-eating, Sarcopenia, Anorexia, Cachexia, Diabetes, NAFLD/NASH, Food Allergy, Constipation, IBD...
Complementary to our in vivo pharmacology services, we offer Histology and Omics enabling deciphering the efficacy and MoA of Health Products in the metabolic, GI and Ageing spaces.
Localisation : Marseille - France
Biomeostasis
https://www.biomeostasis.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 14 Feb 2024 | | |